The natural history of Parkinson's disease in LRRK2 G2019S carriers

被引：0
|
作者：
Kmiecik, M.
Coker, D.
Heilbron, K.
Aslibekyan, S.
Shelton, J.
Cannon, P.
Norcliffe-Kaufmann, L.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1126
引用
收藏
页码：S497 / S497
页数：1
相关论文
共 50 条
  • [31] Montreal cognitive assessment in LRRK2 G2019S carriers versus matched controls with Parkinson disease
    Gunzler, Steven
    Riley, David
    Chen, Shu
    Tatsuoka, Curtis
    Johnson, William
    Mieyal, John
    Walter, Ellen
    Whitney, Christina
    Feng, I. Jung
    Wilson-Delfosse, Amy
    MOVEMENT DISORDERS, 2018, 33 : S98 - S98
  • [32] Differential Phospho-Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease
    Garrido, Alicia
    Santamaria, Enrique
    Fernandez-Irigoyen, Joaquin
    Soto, Marta
    Simonet, Cristina
    Fernandez, Manel
    Obiang, Donina
    Tolosa, Eduardo
    Marti, Maria-Jose
    Padmanabhan, Shalini
    Malagelada, Cristina
    Ezquerra, Mario
    Fernandez-Santiago, Ruben
    MOVEMENT DISORDERS, 2022, 37 (05) : 1004 - 1015
  • [33] Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2
    Mortiboys, Heather
    Johansen, Krisztina K.
    Aasly, Jan O.
    Bandmann, Oliver
    NEUROLOGY, 2010, 75 (22) : 2017 - 2020
  • [34] Clinical evaluation of asymptomatic G2019S LRRK2 mutation carriers and assessment of factors influencing LRRK2 related Parkinson's disease expression (the ASAP LRRK2 study)
    Gaig, C.
    Tolosa, E.
    Ezguerra, M.
    Rojo, A.
    Aguilar, M.
    Hernandez, J.
    Miquel, F.
    Calopa, M.
    Pastor, P.
    MOVEMENT DISORDERS, 2007, 22 : S173 - S173
  • [35] Leukocyte MAPK activity associated with the LRRK2 G2019S mutation and Parkinson's disease
    Aasly, Jan O.
    Toft, Mathias
    Kvam, Sylvia N.
    Farrer, Matthew J.
    White, Linda R.
    ANNALS OF NEUROLOGY, 2006, 60 : S9 - S9
  • [36] Fall Risk and Gait in Parkinson's Disease: The Role of the LRRK2 G2019S Mutation
    Mirelman, Anat
    Heman, Talia
    Yasinovsky, Kira
    Thaler, Avner
    Gurevich, Tanya
    Marder, Karen
    Bressman, Susan
    Bar-Shira, Anat
    Orr-Urtreger, Avi
    Giladi, Nir
    Hausdorff, Jeffrey M.
    MOVEMENT DISORDERS, 2013, 28 (12) : 1683 - 1690
  • [37] Escaping Parkinson's disease:: A neurologically healthy octogenarian with the LRRK2 G2019S mutation
    Kay, DM
    Kramer, P
    Higgins, D
    Zabetian, CP
    Payami, H
    MOVEMENT DISORDERS, 2005, 20 (08) : 1077 - 1078
  • [38] DEEP PHENOTYPING OF THE G2019S LRRK2 MUTATION IN PARKINSON'S DISEASE: UCL COHORT
    Rizig, Mie
    Jonvik, Hallgeir
    Foltynie, Thomas
    Limousin, Patricia
    Bhatia, Kailash
    Warner, Thomas
    Morris, Huw
    Wood, Nicholas
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [39] G2019S LRRK2 mutation in French and North African families with Parkinson's disease
    Lesage, S
    Ibanez, P
    Lohmann, E
    Pollak, P
    Tison, F
    Tazir, M
    Leutenegger, AL
    Guimaraes, J
    Bonnet, AM
    Agid, Y
    Dürr, A
    Brice, A
    ANNALS OF NEUROLOGY, 2005, 58 (05) : 784 - 787
  • [40] Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease
    Tiziana Squillaro
    Franca Cambi
    Giuseppe Ciacci
    Simone Rossi
    Monica Ulivelli
    Alessandro Malandrini
    Maria Antonietta Mencarelli
    Francesca Mari
    Alessandra Renieri
    Francesca Ariani
    Journal of Human Genetics, 2007, 52 : 201 - 204
12345